Recent News

Latest GeoVax News

  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
122
Current President & CEO Robert McNally to Retire Effective August 31 GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that David...
Last modified on Continue reading
171
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines using its novel viral vector platform technology, announced its financial results for the quarter ended...
Last modified on Continue reading
247
GeoVax Continues Expansion of its MVA-VLP Vaccine Pipeline with Multiple Collaborations in Infectious Disease and Immuno-oncology ATLANTA, GA, July 30, 2018 – GeoVax Labs, Inc. (OTCQB: GOVX),...
Last modified on Continue reading
288
GeoVax Labs, Inc. (OTCQB: GOVX), winner of the 2018 “Best Biotech” at the Vaccine Industry Excellence (ViE) Awards during the World Vaccine Congress, announced today that...
Last modified on Continue reading
664
GeoVax Labs, Inc. (OTCQB: GOVX), winner of the 2018 “Best Biotech” Vaccine Industry Excellence Award at the World Vaccine Congress, announced today that it will be...
Last modified on Continue reading